Clinical trial Retterspitz lotion in patients with various manifestations of injuries of the muscular, tendon and joint system
- Conditions
- various manifestations of muscle, tendon and joint injuries
- Registration Number
- DRKS00020252
- Lead Sponsor
- Retterspitz GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Patients with acute injuries of the muscles, tendons and joint system, which are not permanently in need of therapy nature.
- The trauma must not be older than 48 hours.
- Occurrence of at least one of the following complaints:
- bruise
- Strain
- tension
- swelling
- Sprain
- hematoma
- Patients with an open wound on the affected part of the body
- Patients with fractures, torn ligaments, surgical interventions, recurrent chronic complaints and local skin infections, which do not allow the study medication.
- Patients taking anticoagulation or anti-platelet drugs
- permanent use of painkillers
- Use of steroidal or non-steroidal anti-inflammatory drugs within 48 hours of the onset of injury (topically, orally or intravenously)
- Age <18,> 85
- Allergy or intolerance to one or more of the ingredients used
- Pregnancy and breast feeding period
- Inability to adequately participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Objectifiable representation of the effectiveness of Retterspitz lotion. Measurement of the type of complaint and the intensity of the complaints using a visual analog scale (VAS) from 0 (no complaints) to 10 (strongest complaints imaginable).<br>Change in the symptoms using a standardized questionnaire at identical times (days 1, 4 and 8) by means of standardized assessment of the degree of complaint using a visual analogue scale from 0 (no complaints) to 10 (strongest complaints imaginable)
- Secondary Outcome Measures
Name Time Method Side effect related to the application